Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab vs Lapatinib in Metastatic HER2+ Breast Cancer
NCT00842998Phase 2Unknown
- Sponsor
- Azienda Ospedaliera Ordine Mauriziano di Torino
- Start
- Feb 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by Azienda Ospedaliera Ordine Mauriziano di Torino. Status: unknown.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00842998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00842998.